BackUnited Therapeutics Overview

United Therapeutics Profit Margin

Latest profit margin for United Therapeutics: 40.61% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

35.18%
13.27% YoY

As of Mar 2026

Annual Profit Margin (TTM)

40.61%
0.44% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

United Therapeutics (UTHR) FAQ

As of the most recent data (March 2026), UTHR shows a profit margin of 40.61%. That compares with 40.44% in the prior-year period — up 0.4% year over year. That is above the Healthcare sector average of 15.29%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, UTHR's profit margin is now 40.61% (was 40.44%) — a 0.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether United Therapeutics is outperforming or lagging.

The Healthcare sector average profit margin is about 15.29%. United Therapeutics is at 40.61%, which is higher that average. That is roughly 165.6% above the sector mean. Use the comparison chart on this page to see how UTHR stacks up against individual peers as well.

That compares with 40.44% in the prior-year period — up 0.4% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare United Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has United Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 40.61%) with ownership activity and broader fundamentals.